Our Team

Our Team

credit: Unsplash

Together with our experienced and esteemed research and physician partners, we are a highly motivated and passionate team that aims to efficiently develop treatment solutions to improve patients’ lives

Together with our experienced and esteemed research and physician partners, we are a highly motivated and passionate team that aims to efficiently develop treatment solutions to improve patients’ lives

Shlomi Schneider

Co-founder, Chairman of the Board

Adi Moreh

Co-founder, Board Member

Yaniv Glazer

CEO

Cheryl Fitzer-Attas, PhD, MBA

Senior Advisor

Dan Fishelovitch, PhD

CMC lead

Yossi Gilgun-Sherki, PhD, MBA

Head of Product Development

Doron M. Shinar, PhD, DABT

Pre-clinical and toxicology lead

Advisors

Dr. Or Kakhlon,

PhD

Hadassah Medical School

Prof. Miguel Weil,

PhD

Tel Aviv University

  • Or Kakhlon ​- an expert in neurometabolic disorders mainly interested in mechanistic-based development of novel pharmacological therapies.
  • Miguel Weil -a highly experienced cell biologist and drug screening assay developer in the field of personalized medicine and neurodegenerative diseases.
Both are the patent co-inventors and principal investigators behind the discovery of the novel GHF drugs.

Collaborators

Prof. Alexander Lossos,

MD

Hadassah Ein Kerem

Anat Mordechai,

RN, MSc

Hadassah Ein Kerem

Prof. Nissim Garti,

PhD, MBA

Lyotropic Delivery Systems Ltd. (LDS)

  • Alexander Lossos – a world leading ABPD specialist whose work pioneered to the identification of the biochemical and molecular basis of the disease. (Jerusalem, Israel).
  • Anat Mordechai – Clinical study and project coordinator.
  • Nissim Garti – an award-winning Professor Emeritus of Chemistry (Hebrew University, Jerusalem, Israel); inventor of nanodroplets (used in our oral formulations), for enhanced drug delivery and founder of LDS, Lyotropic Delivery System.

Research Foundation & Patient Society

APBD Research Foundation – a non-profit health organization dedicated solely to finding the cause and cure for APBD (New York, NY).

Mifneh – an Israeli NPO dedicated to the supporting of patients with APBD and carers, increasing awareness, improving diagnosis, and supporting research in the field.

Disclaimer

All the mentioned in this website, including the content, wording, statements & expressions are soleley the opinion of the company that owns this website. We hereby inform you that we may, at our sole discretion to change the website, its content, wording, statements & expressions without prior notice. 

For removal of doubt, it is clarified that the Company will not be held responsible and will not be considered in any case liable and it shall not bear any kind of liability (directly or indirectly) to any decisions and/or actions made by any of the readers, subscribers of this website or any one entering the website. 

It is strongly recommended that any action and/or decision shall be be discussed with a professional before taken. 

The information contained in this website or any other advertisement materials are provided as an information service only. For removal of doubt, the accuracy or completeness of the information is not warranted and cannot be taken into account in cay action.

*  Required Field

    I agree to receive updates about GHF.


    Skip to content